share_log

华人健康(301408.SZ)：一直致力于打造集医药零售、医药代理、终端集采、研发生产

Chinese Health (301408.SZ) has always been committed to building a combination of pharmaceutical retail, pharmaceutical agency, terminal procurement, and R&D production.

Gelonghui Finance ·  Aug 7 06:01

On August 7th, Grace Health (301408.SZ) stated on the investor interaction platform that the company has been committed to creating an ecological enterprise with a comprehensive layout centered around a highly penetrating pharmaceutical retail ecosystem network, and achieving balanced development, benign cooperation, and complementary advantages in its four major business sectors of pharmaceutical retail, pharmaceutical agency, terminal procurement, and R&D production. In the future, the company will continue to follow the development strategy of combining internal growth with external expansion, carefully evaluate investment and M&A opportunities that meet the company's strategic objectives while doing a good job in its existing main business, actively explore new profit growth points, and enhance the company's overall competitiveness to create greater value for all shareholders.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment